Starlink Plans Satellite Orbit Reconfiguration in 2026 to Boost Space Safety 
Novo Nordisk and Eli Lilly Cut Obesity Drug Prices in China, Boosting Access to Wegovy and Mounjaro 
Lockheed Martin Secures Nearly $500 Million in U.S. and Allied Defense Contracts 
Lockheed Martin Secures $328.5 Million U.S. Defense Contract for Advanced Systems Supporting Taiwan Air Force 
Neuralink Plans Automated Brain Implant Surgeries and Mass Production by 2026 
Boeing Secures Major $2.7 Billion U.S. Military Contract for Apache Helicopter Support 
Vanda Pharmaceuticals Wins FDA Approval for New Motion Sickness Drug After Four Decades 
Samsung Electronics Secures Annual U.S. Licence for China Chip Equipment Imports in 2026 
Google Accelerates AI Infrastructure With Ironwood TPU Expansion in 2026 
Bain Capital Moves to Acquire Majority Stake in Echo Marketing 
SoftBank Completes $41 Billion OpenAI Investment in Historic AI Funding Round 
Air China Orders 60 Airbus A320neo Jets in $9.5 Billion Deal as Airbus Strengthens Grip on China Market 
ByteDance Plans Massive AI Chip Spending Boost as Nvidia Demand Grows in China 
Elon Musk’s xAI Expands Supercomputer Infrastructure With Third Data Center to Boost AI Training Power 
Drugmakers Plan 2026 U.S. Price Increases on Over 350 Branded Medications Despite Political Pressure 
Disney Agrees to $10 Million Settlement Over Child Privacy Violations on YouTube 
Novolyze, a company specialized in Preventive Control Validation, recently announced the addition of 4 new references to its SurroNov range of dry and ready-to-use surrogate microorganisms. With these new products, Novolyze offers an off-the-shelf solution to the food industry for assessing the impact of a thermal process - such as baking, extrusion, drying, etc. - on the inactivation of Salmonella. The released products aim at facilitating preventive control validation studies for the following food applications:
Nuts & Seeds (SurroNov 1822)
Pet Food & Animal Feed (SurroNov 1824)
Herbs & Spices (SurroNov 1826)
Biscuits & Snacks (SurroNov 1832)
These four new items have been tested to have a similar / greater resistance than Salmonella in their respective food application. Tests included inactivation studies on such food matrices as kernel pistachios, pet food kibbles, black pepper, paprika and cookie dough.
As a reminder, surrogate microorganisms are non-pathogenic bacteria that mimic the behavior of foodborne pathogens to different kinds of stress (heat etc.). Since they are not pathogenic, they can be safely used in-plant to validate the efficacy of a preventive control, a cornerstone requirement of FSMA. SurroNov surrogate microorganisms are commercialized as a ready-to-use powder preparation that does not require any further enrichment step before use. They are available in individual pouches from 25g to 1kg at concentrations up to 10-log CFU/g. Their inoculation on a food product is usually obtained by blending.
Novolyze has already announced the launch of new surrogate references in the near future, to cover different food applications.
Contact
Pierre-Olivier BEAL Business Development Manager
T (France) : +33 781 865 563
T (USA) : +1 (617) 500-8536
